
|Articles|January 23, 2014
ACM Global Central Lab's Acquisition Expands Asia-Pac Presence
ACM Global Central Lab announced it has acquired Phoenix Pharma Central Services
Advertisement
ACM Global Central Lab announced it has acquired Phoenix Pharma Central Services (S) Pte. Ltd (Phoenix PCS), a central laboratory services provider for clinical trials in the Asia-Pacific region, by adding two clinical trial laboratory locations in Singapore and Shanghai, China. The addition of these laboratories, comes on the heels of last year’s expansion and relocation of its ACM York facilities.
Read the full release
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters
2
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
3
ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma
4
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
5



